Your browser doesn't support javascript.
loading
Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Sanikini, Harinakshi; Muller, David C; Sophiea, Marisa; Rinaldi, Sabina; Agudo, Antonio; Duell, Eric J; Weiderpass, Elisabete; Overvad, Kim; Tjønneland, Anne; Halkjaer, Jytte; Boutron-Ruault, Marie-Christine; Carbonnel, Franck; Cervenka, Iris; Boeing, Heiner; Kaaks, Rudolf; Kühn, Tilman; Trichopoulou, Antonia; Martimianaki, Georgia; Karakatsani, Anna; Pala, Valeria; Palli, Domenico; Mattiello, Amalia; Tumino, Rosario; Sacerdote, Carlotta; Skeie, Guri; Rylander, Charlotta; Chirlaque López, María-Dolores; Sánchez, Maria-Jose; Ardanaz, Eva; Regnér, Sara; Stocks, Tanja; Bueno-de-Mesquita, Bas; Vermeulen, Roel C H; Aune, Dagfinn; Tong, Tammy Y N; Kliemann, Nathalie; Murphy, Neil; Chadeau-Hyam, Marc; Gunter, Marc J; Cross, Amanda J.
Afiliação
  • Sanikini H; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Muller DC; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Sophiea M; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
  • Rinaldi S; Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.
  • Agudo A; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Duell EJ; Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
  • Weiderpass E; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Overvad K; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
  • Tjønneland A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Halkjaer J; Genetic Epidemiology Group, Folkhälsan Research Center, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Boutron-Ruault MC; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Carbonnel F; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Cervenka I; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Boeing H; CESP, Faculté de Médecine, Université Paris-Sud, Villejuif, France.
  • Kaaks R; Faculté de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Kühn T; Institut Gustave Roussy, Villejuif, France.
  • Trichopoulou A; CESP, Faculté de Médecine, Université Paris-Sud, Villejuif, France.
  • Martimianaki G; Faculté de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Karakatsani A; Institut Gustave Roussy, Villejuif, France.
  • Pala V; Department of Gastroenterology, Bicêtre University Hospital, Assistance Publique des Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Palli D; CESP, Faculté de Médecine, Université Paris-Sud, Villejuif, France.
  • Mattiello A; Faculté de Médecine, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Tumino R; Institut Gustave Roussy, Villejuif, France.
  • Sacerdote C; Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Nuthetal, Germany.
  • Skeie G; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rylander C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chirlaque López MD; Hellenic Health Foundation, Athens, Greece.
  • Sánchez MJ; Hellenic Health Foundation, Athens, Greece.
  • Ardanaz E; Hellenic Health Foundation, Athens, Greece.
  • Regnér S; Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.
  • Stocks T; Epidemiology and Prevention Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bueno-de-Mesquita B; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.
  • Vermeulen RCH; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Aune D; Cancer Registry and Histopathology Department, "Civic - M. P. Arezzo" Hospital, ASP, Ragusa, Italy.
  • Tong TYN; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
  • Kliemann N; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Murphy N; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
  • Chadeau-Hyam M; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Gunter MJ; CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Cross AJ; Department of Health and Social Sciences, Murcia University, Murcia, Spain.
Int J Cancer ; 146(4): 929-942, 2020 02 15.
Article em En | MEDLINE | ID: mdl-31050823
ABSTRACT
Obesity has been associated with upper gastrointestinal cancers; however, there are limited prospective data on associations by subtype/subsite. Obesity can impact hormonal factors, which have been hypothesized to play a role in these cancers. We investigated anthropometric and reproductive factors in relation to esophageal and gastric cancer by subtype and subsite for 476,160 participants from the European Prospective Investigation into Cancer and Nutrition cohort. Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox models. During a mean follow-up of 14 years, 220 esophageal adenocarcinomas (EA), 195 esophageal squamous cell carcinomas, 243 gastric cardia (GC) and 373 gastric noncardia (GNC) cancers were diagnosed. Body mass index (BMI) was associated with EA in men (BMI ≥30 vs. 18.5-25 kg/m2 HR = 1.94, 95% CI 1.25-3.03) and women (HR = 2.66, 95% CI 1.15-6.19); however, adjustment for waist-to-hip ratio (WHR) attenuated these associations. After mutual adjustment for BMI and HC, respectively, WHR and waist circumference (WC) were associated with EA in men (HR = 3.47, 95% CI 1.99-6.06 for WHR >0.96 vs. <0.91; HR = 2.67, 95% CI 1.52-4.72 for WC >98 vs. <90 cm) and women (HR = 4.40, 95% CI 1.35-14.33 for WHR >0.82 vs. <0.76; HR = 5.67, 95% CI 1.76-18.26 for WC >84 vs. <74 cm). WHR was also positively associated with GC in women, and WC was positively associated with GC in men. Inverse associations were observed between parity and EA (HR = 0.38, 95% CI 0.14-0.99; >2 vs. 0) and age at first pregnancy and GNC (HR = 0.54, 95% CI 0.32-0.91; >26 vs. <22 years); whereas bilateral ovariectomy was positively associated with GNC (HR = 1.87, 95% CI 1.04-3.36). These findings support a role for hormonal pathways in upper gastrointestinal cancers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article